VYNE Therapeutics Inc.
Clinical-stage biopharma developing novel therapies for immuno-inflammatory diseases.
VYNE | US
Overview
Corporate Details
- ISIN(s):
- US92941V1008 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 685 ROUTE 202/206 N., SUITE 301, 8807 BRIDGEWATER
- Website:
- https://vynetherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary, innovative, and differentiated therapies. The company is dedicated to treating immuno-inflammatory conditions and other complex therapeutic challenges. Its core mission is to address unmet patient needs by developing novel treatments for chronic inflammatory and immunological diseases, questioning traditional assumptions to find improved solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all VYNE Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VYNE Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VYNE Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
